Policy & Ethics

In complex systems, intermediaries can “grease the wheels” by lowering transaction costs, streamlining logistics, and bridging information gaps.

In one of the most consequential institutional changes at the EPA in decades, Deputy Administrator David Fotouhi announced in an internal memo that the EPA will no longer use the Integrated Risk Information System (IRIS) program to develop c

There is a tale, often retold in modern healthcare discourse: the tension between not only two competing industries, but, more importantly, two different ideologies concerning the nature of the scientific method and its philosophical foundat

On November 24, 2024, before taking office to start his second term, then-President-elect Trump nominated Dr. Janette Neshiewat, a Fox News medical commentator, to become the next Surgeon General of the United States.

ACSH is pleased to announce that Dr. Lynn Webster has joined our Board of Scientific Advisors. A nationally recognized expert in pain medicine and addiction, he brings deep clinical and research expertise to the organization.

Join Cameron English and Dr. Chuck Dinerstein on the Science Dispatch podcast as they discuss:

For a decade now, the so-called “opioid crisis” has been framed almost entirely in one narrative direction. We were made aware, and rightly so, of overdose deaths, pill mills, and other forms of reckless and irresponsible prescribing.

A movement is underway to classify heavy social media use as a form of addiction. Advocacy groups, plaintiffs’ attorneys, and a growing number of lawmakers are treating the proposition as settled science.

Another, more potent synthetic opioid has begun appearing in forensic laboratories: cychlorphine.